Gene · 7423
Papers4,111
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,111
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New Ideas for the Prevention and Treatment of Preeclampsia and Their Molecular Inspirations. | Int J Mol Sci | 2023 | 37569476 | PubTator, text mining | PubMed |
| Dysregulations of Key Regulators of Angiogenesis and Inflammation in Abdominal Aortic Aneurysm. | Int J Mol Sci | 2023 | 37569462 | PubTator, text mining | PubMed |
| Effect of Inflammatory Microenvironment on the Regenerative Capacity of Adipose-Derived Mesenchymal Stem Cells. | Cells | 2023 | 37566046 | PubTator, text mining | PubMed |
| Genes That Extend Lifespan May Do So by Mitigating the Increased Risk of Death Posed by Having Hypertension. | Am J Hypertens | 2023 | 37561089 | PubTator, text mining | PubMed |
| Prostaglandin-endoperoxide synthase 2 (PTGS2) gene expression and its association with genes regulating the VEGF signaling pathway in head and neck squamous cell carcinoma. | J Oral Biol Craniofac Res | 2023 | 37559688 | PubTator, text mining | PubMed |
| The splicing factor YBX1 promotes the progression of osteosarcoma by upregulating VEGF165 and downregulating VEGF165b. | Heliyon | 2023 | 37554848 | PubTator, text mining | PubMed |
| Dynamic human retinal pigment epithelium (RPE) and choroid architecture based on single-cell transcriptomic landscape analysis. | Genes Dis | 2023 | 37554187 | PubTator, text mining | PubMed |
A TRANSCRIPTOMIC APPRECIATION OF CHILDHOOD MENINGOCOCCAL AND POLYMICROBIAL SEPSIS FROM A PRO-INFLAMMATORY AND TRAJECTORIAL PERSPECTIVE, A ROLE FOR VASCULAR ENDOTHELIAL GROWTH FACTOR A AND B MODULATION? | Shock | 2023 | 37553892 | PubTator, text mining | PubMed |
| Discovery of Aptamers and the Acceleration of the Development of Targeting Research in Ophthalmology. | Int J Nanomedicine | 2023 | 37551274 | PubTator, text mining | PubMed |
| Tight junction disruption and the pathogenesis of the chronic complications of diabetes mellitus: A narrative review. | World J Diabetes | 2023 | 37547580 | PubTator, text mining | PubMed |
| Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study. | Front Oncol | 2023 | 37546402 | PubTator, text mining | PubMed |
| A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia. | Nat Commun | 2023 | 37542039 | PubTator, text mining | PubMed |
| SAIF plays anti-angiogenesis via blocking VEGF-VEGFR2-ERK signal in tumor treatment. | Heliyon | 2023 | 37539189 | PubTator, text mining | PubMed |
| The role of cellular crosstalk in the progression of diabetic nephropathy. | Front Endocrinol (Lausanne) | 2023 | 37538798 | PubTator, text mining | PubMed |
| Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study. | Nat Commun | 2023 | 37537219 | PubTator, text mining | PubMed |
| Therapeutic application of regeneration-associated cells: a novel source of regenerative medicine. | Stem Cell Res Ther | 2023 | 37533070 | PubTator, text mining | PubMed |
| SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression. | Cancer Cell Int | 2023 | 37525212 | PubTator, text mining | PubMed |
| Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets. | Signal Transduct Target Ther | 2023 | 37518181 | PubTator, text mining | PubMed |
| Prevention and Treatment of Retinal Vein Occlusion: The Role of Diet-A Review. | Nutrients | 2023 | 37513655 | PubTator, text mining | PubMed |
| Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments. | J Pers Med | 2023 | 37511745 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7423/papers?page=18